Author

José Alberto Nakauma‐González

Erasmus MCORCID 0000-0002-9153-4280Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ameneh BazrafshaniD· 1 shared Andrea SacchettiiD· 1 shared Annelies de KleiniD· 1 shared Bert Eussen· 1 shared Bram TorenvlietiD· 1 shared Geert J.L.H. van LeendersiD· 1 shared Joost L. BoormansiD· 1 shared Leila BeikmohammadiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ameneh BazrafshanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrative analysis of patient-derived tumoroids and ex vivo organoid modeling of ARID1A loss in bladder cancer reveals therapeutic molecular targets

Mathijs P. Scholtes, Maryam Akbarzadeh, Αλέξανδρος Γαλάρας, José Alberto Nakauma‐González, Ameneh Bazrafshan, Vandana Solanki, Bram Torenvliet, Leila Beikmohammadi, Valeria Lozovanu, Shahla Romal, Panagiotis Moulos, Nikoleta Vavouraki, Tsung Wai Kan, Mahesh Algoe, Martin E. van Royen, , Tokameh Mahmoudi

The paper identifies CHEK1 and BIRC5 as therapeutic targets in ARID1A-deficient bladder cancer using patient-derived tumoroids and public datasets.

Cancer Letters · Jan 30, 2025Peer-reviewedCancer Biology